Patent ductus arteriosus

Active Ingredient: Ibuprofen

Indication for Ibuprofen

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old)
Therapeutic intent: Curative procedure

Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.

For this indication, competent medicine agencies globally authorize below treatments:

10 mg/kg once given after the first 6 hours of life and thereafter 2 injections of 5 mg/kg given at 24-hour intervals

For:

Dosage regimens

Intravenous, 10 milligrams ibuprofen per kilogram of body weight, one dose, over the duration of 24 hours. Afterwards, intravenous, 5 milligrams ibuprofen per kilogram of body weight, once every 24 hours, 2 doses in total.

Detailed description

Treatment with ibuprofen should only be carried out in a neonatal intensive care unit under the supervision of an experienced neonatologist.

A course of therapy is defined as three intravenous injections of ibuprofen given at 24-hour intervals. The first injection should be given after the first 6 hours of life.

The ibuprofen dose is adjusted to the body weight as follows:

  • 1st injection: 10 mg/kg,
  • 2nd and 3rd injections: 5 mg/kg.

If anuria or manifest oliguria occurs after the first or second dose, the next dose should be withheld until urine output returns to normal levels.

If the ductus arteriosus/em> does not close 48 hours after the last injection or if it re-opens, a second course of 3 doses, as above, may be given.

If the condition is unchanged after the second course of therapy, surgery of the patent ductus arteriosus may then be necessary.

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.